BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lee HM, Okuda KS, González FE, Patel V. Current Perspectives on Nasopharyngeal Carcinoma. Adv Exp Med Biol 2019;1164:11-34. [PMID: 31576537 DOI: 10.1007/978-3-030-22254-3_2] [Cited by in Crossref: 32] [Cited by in F6Publishing: 22] [Article Influence: 10.7] [Reference Citation Analysis]
Number Citing Articles
1 Yang Y, Ren ZZ, Wei WJ, He ZL, Deng YL, Wang Z, Fan YC, Zhou J, Jiang LH. Study on the biological mechanism of urolithin a on nasopharyngeal carcinoma in vitro. Pharm Biol 2022;60:1566-77. [PMID: 35952389 DOI: 10.1080/13880209.2022.2106251] [Reference Citation Analysis]
2 Xu K, De Ravin E, Suresh N, Brody RM, Rajasekaran K. A comprehensive review and characterization of nasopharyngeal carcinoma clinical trials. World j otorhinolaryngol -head neck surg . [DOI: 10.1002/wjo2.80] [Reference Citation Analysis]
3 Soldan SS, Messick TE, Lieberman PM. Therapeutic approaches to Epstein-Barr virus cancers. Curr Opin Virol 2022;56:101260. [PMID: 36174496 DOI: 10.1016/j.coviro.2022.101260] [Reference Citation Analysis]
4 Wen J, Chen G, Li J, Luo J, He J, Wang R, Qin L, Khawar MB. Downregulated miR-150-5p in the Tissue of Nasopharyngeal Carcinoma. Genetics Research 2022;2022:1-13. [DOI: 10.1155/2022/2485055] [Reference Citation Analysis]
5 Wang S, Chen S, Zhong Q, Liu Y. Immunotherapy for the treatment of advanced nasopharyngeal carcinoma: a promising new era. J Cancer Res Clin Oncol 2022. [PMID: 35876949 DOI: 10.1007/s00432-022-04214-8] [Reference Citation Analysis]
6 Gong X, Wang L, Wu W, Li Y, Long J, Chen X, Luo X, He Q, Bi T, Li Z, Luomeng Y, Jin F, Shen Y. The Treatment Combining Antiangiogenesis with Chemoradiotherapy Impinges on the Peripheral Circulation Vascular Endothelial Cells and Therapeutic Effect in the Patients with Locally Advanced Nasopharyngeal Carcinoma. BioMed Research International 2022;2022:1-7. [DOI: 10.1155/2022/1787854] [Reference Citation Analysis]
7 Yang H, Bao Y, Jin F, Jiang C, Wei Z, Liu Z, Xu Y. Ceruloplasmin inhibits the proliferation, migration and invasion of nasopharyngeal carcinoma cells and is negatively regulated by miR-543. Nucleosides Nucleotides Nucleic Acids 2022;41:474-88. [PMID: 35306965 DOI: 10.1080/15257770.2022.2052314] [Reference Citation Analysis]
8 Zhu J, Fang R, Pan Z, Qian X. Circulating lymphocyte subsets are prognostic factors in patients with nasopharyngeal carcinoma. BMC Cancer 2022;22:716. [PMID: 35768843 DOI: 10.1186/s12885-022-09438-y] [Reference Citation Analysis]
9 Luo X, Jiang Q, Liu L, Liao Q, Yu J, Xiang Z, Gong Y. METTL3-mediated m6A modification promotes processing and maturation of pri-miRNA-19a to facilitate nasopharyngeal carcinoma cell proliferation and invasion. Physiol Genomics 2022. [PMID: 35759451 DOI: 10.1152/physiolgenomics.00007.2022] [Reference Citation Analysis]
10 Sun Y, Liu Y, Du Z, Zhou L, Chen Q, Chu H. CircSOX9 acts as a molecular sponge of miR-485-3p to promote the progression of nasopharyngeal carcinoma. Aging (Albany NY) 2022;14:4914-26. [PMID: 35700516 DOI: 10.18632/aging.204127] [Reference Citation Analysis]
11 Li Z, Shen L, Li Y, Shen L, Li N. Identification of pyroptosis-related gene prognostic signature in head and neck squamous cell carcinoma. Cancer Med 2022. [PMID: 35574984 DOI: 10.1002/cam4.4825] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Yang Q, Nie YH, Cai MB, Li ZM, Zhu HB, Tan YR. Gemcitabine Combined with Cisplatin Has a Better Effect in the Treatment of Recurrent/Metastatic Advanced Nasopharyngeal Carcinoma. Drug Des Devel Ther 2022;16:1191-8. [PMID: 35502425 DOI: 10.2147/DDDT.S353898] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Song Y, Cheng W, Li H, Liu X. The global, regional, national burden of nasopharyngeal cancer and its attributable risk factors (1990-2019) and predictions to 2035. Cancer Med 2022. [PMID: 35475595 DOI: 10.1002/cam4.4783] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Zheng J, Zhao Z, Ren H, Wang Y, Meng X, Zhang W, Zhang C, Ming L, Lu X. LncRNA HCG11 Facilitates Nasopharyngeal Carcinoma Progression Through Regulating miRNA-490-3p/MAP3K9 Axis. Front Oncol 2022;12:872033. [PMID: 35463310 DOI: 10.3389/fonc.2022.872033] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Yue H, Zhu H, Luo D, Du Q, Xie Y, Huang S, Liu W, Tang M. Differentially Expressed Genes in Nasopharyngeal Carcinoma Tissues and Their Correlation with Recurrence and Metastasis of Nasopharyngeal Carcinoma. Computational and Mathematical Methods in Medicine 2022;2022:1-9. [DOI: 10.1155/2022/1941412] [Reference Citation Analysis]
16 Sun X, Zhou J, Zhang Z. Cullin 4A/protein arginine methyltransferase 5 (CUL4A/PRMT5) promotes cell malignant phenotypes and tumor growth in nasopharyngeal carcinoma. Bioengineered 2022;13:8712-23. [PMID: 35333690 DOI: 10.1080/21655979.2022.2054756] [Reference Citation Analysis]
17 Wen J, Qin L, Chen G, Huang H, Shen M, Pang J, Tang Y, Lu W, Wang R, Luo J, Rai SN. Downregulation of MicroRNA-1 and Its Potential Molecular Mechanism in Nasopharyngeal Cancer: An Investigation Combined with In Silico and In-House Immunohistochemistry Validation. Disease Markers 2022;2022:1-13. [DOI: 10.1155/2022/7962220] [Reference Citation Analysis]
18 Zhou J, Zhang B, Zhang X, Wang C, Xu Y. Identification of a 3-miRNA Signature Associated With the Prediction of Prognosis in Nasopharyngeal Carcinoma. Front Oncol 2021;11:823603. [PMID: 35155213 DOI: 10.3389/fonc.2021.823603] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
19 Wu N, Tu Y, Fan G, Ding J, Luo J, Wang W, Zhang C, Yuan C, Zhang H, Chen P, Tan S, Xiao H. Enhanced photodynamic therapy/photothermotherapy for nasopharyngeal carcinoma via a tumour microenvironment-responsive self-oxygenated drug delivery system. Asian Journal of Pharmaceutical Sciences 2022. [DOI: 10.1016/j.ajps.2022.01.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
20 Xu Y, Liu Y, Wang Z, Wang J, Zhang J, Chen X, Wu R, Liu Q, Qu Y, Wang K, Huang X, Luo J, Gao L, Xu G, Zhang Y, Yi J. Irradiation-induced nasopharyngeal necrosis (INN) in newly diagnosed nasopharyngeal carcinoma treated by intensity-modulated radiation therapy: clinical characteristics and the influence of treatment strategies. Radiat Oncol 2022;17. [DOI: 10.1186/s13014-022-01980-0] [Reference Citation Analysis]
21 Lu Z, Peng H, Li R, Xu X, Peng J. BarH-like homeobox 2 represses the transcription of keratin 16 and affects Ras signaling pathway to suppress nasopharyngeal carcinoma progression. Bioengineered 2022;13:3122-36. [PMID: 35037835 DOI: 10.1080/21655979.2022.2026549] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
22 Zhang SQ, Liu J, Chen HB, Dai WJ, Zhou LQ, Xie CW, Li JC. A novel three-microRNA signature for predicting survival in patients with nasopharyngeal carcinoma. J Dent Sci 2022;17:377-88. [PMID: 35028061 DOI: 10.1016/j.jds.2021.08.017] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
23 Tu B, Ye L, Cao Q, Gong S, Jiang M, Li H. Identification of a five-miRNA signature as a novel potential prognostic biomarker in patients with nasopharyngeal carcinoma. Hereditas 2022;159:3. [PMID: 34998434 DOI: 10.1186/s41065-021-00214-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
24 Ding Z, Xiang X, Zeng Q, Ma J, Dai Z, Kang K, Bi S. Evaluation of plan robustness on the dosimetry of volumetric arc radiotherapy (VMAT) with set-up uncertainty in Nasopharyngeal carcinoma (NPC) radiotherapy. Radiat Oncol 2022;17:1. [PMID: 34980178 DOI: 10.1186/s13014-021-01970-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
25 Zhang FY, Li X, Huang TT, Xiang ML, Sun LL, Sun ZL. LINC00839 knockdown restrains the metastatic behavior of nasopharyngeal carcinoma by sponging miR-454-3p. Aging (Albany NY) 2021;13:26022-33. [PMID: 34965215 DOI: 10.18632/aging.203792] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
26 Jiang H, He Q, Liu T. BBOX1-AS1 Accelerates Nasopharyngeal Carcinoma Progression by Sponging miR-3940-3p and Enhancing KPNA2 Upregulation. Cancer Manag Res 2021;13:9049-62. [PMID: 34938119 DOI: 10.2147/CMAR.S327211] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
27 Shen L, Li C, Chen F, Shen L, Li Z, Li N. CRISPR/Cas9 genome-wide screening identifies LUC7L2 that promotes radioresistance via autophagy in nasopharyngeal carcinoma cells. Cell Death Discov 2021;7:392. [PMID: 34907164 DOI: 10.1038/s41420-021-00783-8] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
28 Cui Z, Lin Y, Hu D, Wu J, Peng W, Chen Y. Diagnostic and Prognostic Potential of Circulating and Tissue BATF2 in Nasopharyngeal Carcinoma. Front Mol Biosci 2021;8:724373. [PMID: 34778372 DOI: 10.3389/fmolb.2021.724373] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
29 Zhu QY, Zhao GX, Li Y, Talakatta G, Mai HQ, Le QT, Young LS, Zeng MS. Advances in pathogenesis and precision medicine for nasopharyngeal carcinoma. MedComm (2020) 2021;2:175-206. [PMID: 34766141 DOI: 10.1002/mco2.32] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
30 Lyu YH, Lin CY, Xie SH, Li T, Liu Q, Ling W, Lu YQ, Cao SM, Lin AH. Association Between Traditional Herbal Diet and Nasopharyngeal Carcinoma Risk: A Prospective Cohort Study in Southern China. Front Oncol 2021;11:715242. [PMID: 34745941 DOI: 10.3389/fonc.2021.715242] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
31 Sun K, Wang H, Xu X, Wei X, Su J, Zhu K, Fan J. Tumor-Educated Platelet miR-18a-3p as a Novel Liquid-Biopsy Biomarker for Early Diagnosis and Chemotherapy Efficacy Monitoring in Nasopharyngeal Carcinoma. Front Oncol 2021;11:736412. [PMID: 34692511 DOI: 10.3389/fonc.2021.736412] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
32 Gao Y, Liu Z, Liu Y. Cisplatin combined with capecitabine-induced chemotherapy for local nasopharyngeal carcinoma can improve the quality of life and reduce toxic and side effects. World J Surg Oncol 2021;19:280. [PMID: 34535176 DOI: 10.1186/s12957-021-02393-1] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
33 Luo Y, Qu X, Kan D, Cai B. The microRNA-451a/chromosome segregation 1-like axis suppresses cell proliferation, migration, and invasion and induces apoptosis in nasopharyngeal carcinoma. Bioengineered 2021;12:6967-80. [PMID: 34516344 DOI: 10.1080/21655979.2021.1975018] [Reference Citation Analysis]
34 Yan C, Shen DS, Chen XB, Su DK, Liang ZG, Chen KH, Li L, Liang X, Liao H, Zhu XD. CT-Based Radiomics Nomogram for Prediction of Progression-Free Survival in Locoregionally Advanced Nasopharyngeal Carcinoma. Cancer Manag Res 2021;13:6911-23. [PMID: 34512030 DOI: 10.2147/CMAR.S325373] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
35 Yang L, Liu G, Li Y, Pan Y. The emergence of tumor-infiltrating lymphocytes in nasopharyngeal carcinoma: Predictive value and immunotherapy implications. Genes & Diseases 2021. [DOI: 10.1016/j.gendis.2021.07.002] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
36 Ye Q, Guo J, Chen Y, Cui Z, Chen Y. Performance of Plasma HSP90α, Serum EBV VCA IgA Antibody and Plasma EBV DNA for the Diagnosis and Prognosis Prediction of Nasopharyngeal Carcinoma. Cancer Manag Res 2021;13:5793-802. [PMID: 34321926 DOI: 10.2147/CMAR.S320541] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
37 Liang T, Liu W, Xie J, Wang Y, Chen G, Liao W, Song L, Zhang X. Serum EA-IgA and D-dimer, but not VCA-IgA, are associated with prognosis in patients with nasopharyngeal carcinoma: a meta-analysis. Cancer Cell Int 2021;21:329. [PMID: 34193149 DOI: 10.1186/s12935-021-02035-2] [Reference Citation Analysis]
38 Liu Q, Liu L, Mo C, Zhou X, Chen D, He Y, He H, Kang W, Zhao Y, Jin G. Polyethylene glycol-coated ultrasmall superparamagnetic iron oxide nanoparticles-coupled sialyl Lewis X nanotheranostic platform for nasopharyngeal carcinoma imaging and photothermal therapy. J Nanobiotechnology 2021;19:171. [PMID: 34103070 DOI: 10.1186/s12951-021-00918-0] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
39 Liu H, Yang P, Jia Y. Optimal management of oligometastatic nasopharyngeal carcinoma. Eur Arch Otorhinolaryngol 2021. [PMID: 34089384 DOI: 10.1007/s00405-021-06918-y] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
40 Dong W, Dong Q, Ding H. Ophiopogonin B induces reactive oxygen species‑dependent apoptosis through the Hippo pathway in nasopharyngeal carcinoma. Mol Med Rep 2021;24:534. [PMID: 34080657 DOI: 10.3892/mmr.2021.12173] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
41 Luo H, Yi B. The role of Exosomes in the Pathogenesis of Nasopharyngeal Carcinoma and the involved Clinical Application. Int J Biol Sci 2021;17:2147-56. [PMID: 34239345 DOI: 10.7150/ijbs.59688] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
42 Zhu X, Liu L, Wang Y, Cong J, Lin Z, Wang Y, Liu Q, Wang L, Yang B, Li T. lncRNA MIAT/HMGB1 Axis Is Involved in Cisplatin Resistance via Regulating IL6-Mediated Activation of the JAK2/STAT3 Pathway in Nasopharyngeal Carcinoma. Front Oncol 2021;11:651693. [PMID: 34094941 DOI: 10.3389/fonc.2021.651693] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
43 Fu D, Li C, Huang Y. Lipid-Polymer Hybrid Nanoparticle-Based Combination Treatment with Cisplatin and EGFR/HER2 Receptor-Targeting Afatinib to Enhance the Treatment of Nasopharyngeal Carcinoma. Onco Targets Ther 2021;14:2449-61. [PMID: 33859480 DOI: 10.2147/OTT.S286813] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
44 Xu S, Zhou Z, Peng X, Tao X, Zhou P, Zhang K, Peng J, Li D, Shen L, Yang L. EBV-LMP1 promotes radioresistance by inducing protective autophagy through BNIP3 in nasopharyngeal carcinoma. Cell Death Dis 2021;12:344. [PMID: 33795637 DOI: 10.1038/s41419-021-03639-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
45 Liu D, Gong H, Tao Z, Chen S, Kong Y, Xiao B. LINC01515 promotes nasopharyngeal carcinoma progression by serving as a sponge for miR-325 to up-regulate CDCA5. J Mol Histol 2021;52:577-87. [PMID: 33770322 DOI: 10.1007/s10735-021-09969-x] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
46 Li X, Zhang W. Expression of PD-L1 in EBV-associated malignancies. Int Immunopharmacol 2021;95:107553. [PMID: 33765613 DOI: 10.1016/j.intimp.2021.107553] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
47 Zhang L, Lou Z. Nasopharyngeal carcinoma related miRNA detection through a DSN enzyme assisted tetrahedral probe for more accurate prognosis. RSC Adv 2021;11:11398-402. [PMID: 35423657 DOI: 10.1039/d1ra00539a] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
48 Xu S, Lou Z. Ultrasensitive Detection of Nasopharyngeal Carcinoma-Related MiRNA through Garland Rolling Circle Amplification Integrated Catalytic Hairpin Assembly. ACS Omega 2021;6:6460-5. [PMID: 33718736 DOI: 10.1021/acsomega.1c00154] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
49 Li M, Wang Y, Zhao Q, Ma W, Liu J. MiR-30a-5p inhibits proliferation, migration and invasion of nasopharyngeal carcinoma cells by targeting NUCB2. Hum Exp Toxicol 2021;40:1274-85. [PMID: 33567921 DOI: 10.1177/0960327121991913] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
50 Xing B, Qiao XF, Qiu YH, Li X. TMPO-AS1 Regulates the Aggressiveness-Associated Traits of Nasopharyngeal Carcinoma Cells Through Sponging miR-320a. Cancer Manag Res 2021;13:415-25. [PMID: 33488123 DOI: 10.2147/CMAR.S285113] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
51 Sun N, Li Y, Nie P. Standardized nursing and clinical efficacy of OxyContin in reducing oral mucosal pain in patients with nasopharyngeal carcinoma: A randomized, double-blind, placebo-controlled study protocol. Medicine (Baltimore) 2020;99:e23205. [PMID: 33285695 DOI: 10.1097/MD.0000000000023205] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
52 Fan Y, Guan W, Huang R, Lin SY, Song Y, Lu S, Kang L, Yang Q, Lang J, Zhang P. Clinical characteristics and survival outcomes of ascending, descending and mixed types of nasopharyngeal carcinoma in the non-endemic areas of china: A propensity score matching analysis. Cancer Med 2020;9:9315-25. [PMID: 33058559 DOI: 10.1002/cam4.3537] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
53 Li S, Shen L. Impact of tumor volume enlargement after induction chemotherapy on subsequent radiotherapy in locally advanced nasopharyngeal carcinoma: A propensity-score matching analysis. Cancer Med 2020;9:8832-43. [PMID: 33022902 DOI: 10.1002/cam4.3494] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
54 Luo Y, Ma J, Liu F, Guo J, Gui R. Diagnostic value of exosomal circMYC in radioresistant nasopharyngeal carcinoma. Head Neck 2020;42:3702-11. [PMID: 32945062 DOI: 10.1002/hed.26441] [Cited by in Crossref: 4] [Cited by in F6Publishing: 18] [Article Influence: 2.0] [Reference Citation Analysis]
55 Jiang C, Gao H, Zhang L, Li H, Zhang T, Ma J, Liu B. Distribution pattern and prognosis of metastatic lymph nodes in cervical posterior to level V in nasopharyngeal carcinoma patients. BMC Cancer 2020;20:667. [PMID: 32680466 DOI: 10.1186/s12885-020-07146-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
56 Qu W, Li S, Zhang M, Qiao Q. Pattern and prognosis of distant metastases in nasopharyngeal carcinoma: A large-population retrospective analysis. Cancer Med 2020;9:6147-58. [PMID: 32649056 DOI: 10.1002/cam4.3301] [Cited by in Crossref: 3] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
57 Wang J, Kong J, Nie Z, Chen D, Qiang J, Gao W, Chen X. Circular RNA Hsa_circ_0066755 as an Oncogene via sponging miR-651 and as a Promising Diagnostic Biomarker for Nasopharyngeal Carcinoma. Int J Med Sci 2020;17:1499-507. [PMID: 32669952 DOI: 10.7150/ijms.47024] [Cited by in Crossref: 5] [Cited by in F6Publishing: 15] [Article Influence: 2.5] [Reference Citation Analysis]
58 Chen J, Ma C, Zhang Y, Pei S, Du M, Zhang Y, Qian L, Wang J, Yin L, He X. MiR-154-5p Suppresses Cell Invasion and Migration Through Inhibiting KIF14 in Nasopharyngeal Carcinoma. Onco Targets Ther 2020;13:2235-46. [PMID: 32214824 DOI: 10.2147/OTT.S242939] [Cited by in Crossref: 1] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]